Chemical Week Magazine :: Other
Firms invest further— despite tough environment
8:24 AM MDT | October 26, 2012 | —Deepti Ramesh in Madrid
Most pharmaceutical fine chemical manufacturers interviewed by CW at CPhI, the largest annual trade fair for the global pharmaceutical ingredients industry, held recently in Madrid, said they were optimistic about the outlook for the sector and planning a range of investments to grow their businesses. Companies believe that the US FDA’s Generic Drug User Fee Act (GDUFA), which became effective on 1 October 2012, will help eliminate from the market manufacturers with unacceptably low levels of quality. Ananthanarayanan: API unit being built. Schmitz: Decided...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee